glp 1 blindness A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, Rybelsus), the European Medicines Agency (EMA) concluded. https://www.medpagetoday.com/ophthalmology/generalophthalmology/115938?trw=no Study Links GLP-1 Drugs to

Acknowledgments The authors gratefully acknowledge the Xinjiang Horse Industry Association for administrative support, the Zhaosu Stud Farm in Yili Kazakh Autonomous Prefecture for providing experimental animals, the College of Animal Science at Xinjiang Agricultural University for technical expertise, and Xinjiang Chixiao Bojun Animal Husbandry Co., Ltd

Moreover, pharmas didnt have an existing commercial force in obesity and lacked a clear playbook of how they might even go about commercializing such a drug

Here's what we'll cover Here's what we'll cover Here's what we'll cover Key takeaways Oral semaglutide (Rybelsus, Wegovy pill) should be taken daily in the morning, at least 30 minutes before drinking, eating, or taking other medications

A direct head-to-head trial (NCT06662383, 800 patients) is underway with results in December 2026

Bifidobacterium breve : Known for its ability to reduce bloating and support smoother bowel movements

The emergence of GLP-1 agonists like Ozempic is not only reshaping the landscape of weight management and diabetes treatment but also holds promise in addressing alcohol consumption and addiction